Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NURA YASIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1265518567
CMS profile
102968
Location
AUGUSTA, GA

General Payments · PY2018–2024

$2,226.95

  • Reported across 153 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$266.58

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $266.58 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $71.85 4
Acerta Pharma LLC $68.97 4
ABBVIE INC. $56.00 2
Abbott Laboratories $21.74 1
PFIZER INC. $17.54 1
GlaxoSmithKline, LLC. $15.99 1
Amgen Inc. $14.49 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $74.58 5
PY2019 $1,382.90 106
PY2020 $157.66 10
PY2021 $45.55 3
PY2022 $16.11 1
PY2023 $283.57 14
PY2024 $266.58 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.74 02/29/2024 Food and Beverage Undisputed 01/23/2026 1124935906 CMS
ABBVIE INC. $27.95 02/23/2024 Food and Beverage Undisputed 01/23/2026 1106372738 CMS
ABBVIE INC. $28.05 08/20/2024 Food and Beverage Undisputed 01/23/2026 1106372740 CMS
Amgen Inc. $14.49 11/11/2024 Food and Beverage Undisputed 01/23/2026 1116218307 CMS
AstraZeneca Pharmaceuticals LP $18.21 02/03/2024 Food and Beverage Undisputed 01/23/2026 1104466784 CMS
AstraZeneca Pharmaceuticals LP $14.07 03/01/2024 Food and Beverage Undisputed 01/23/2026 1105891194 CMS
AstraZeneca Pharmaceuticals LP $22.86 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105480855 CMS
AstraZeneca Pharmaceuticals LP $13.83 08/30/2024 Food and Beverage Undisputed 01/23/2026 1104256825 CMS
GlaxoSmithKline, LLC. $15.99 11/20/2024 Food and Beverage Undisputed 01/23/2026 1116508999 CMS
Novo Nordisk Inc $15.99 01/23/2024 Food and Beverage Undisputed 01/23/2026 1097748538 CMS
Novo Nordisk Inc $16.46 02/16/2024 Food and Beverage Undisputed 01/23/2026 1096952452 CMS
Novo Nordisk Inc $20.27 03/09/2024 Food and Beverage Undisputed 01/23/2026 1096770833 CMS
Novo Nordisk Inc $19.13 06/17/2024 Food and Beverage Undisputed 01/23/2026 1097761389 CMS
PFIZER INC. $17.54 09/12/2024 Food and Beverage Undisputed 01/23/2026 1132027109 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.